1. Expression Patterns of MOTS-c in Adrenal Tumors: Results from a Preliminary Study.
- Author
-
Kamiński K, Blatkiewicz M, Szyszka M, Olechnowicz A, Komarowska H, Klimont A, Wierzbicki T, Karczewski M, Ruchała M, and Rucinski M
- Subjects
- Humans, Male, Female, Middle Aged, Adult, Mitochondrial Proteins genetics, Mitochondrial Proteins metabolism, Gene Expression Regulation, Neoplastic, Aged, Adrenocortical Adenoma genetics, Adrenocortical Adenoma metabolism, Adrenocortical Adenoma pathology, Adrenocortical Adenoma blood, RNA, Messenger genetics, RNA, Messenger metabolism, Adrenocortical Carcinoma genetics, Adrenocortical Carcinoma metabolism, Adrenocortical Carcinoma pathology, Adrenocortical Carcinoma blood, Biomarkers, Tumor genetics, Biomarkers, Tumor metabolism, Biomarkers, Tumor blood, Adrenal Gland Neoplasms genetics, Adrenal Gland Neoplasms metabolism, Adrenal Gland Neoplasms pathology, Adrenal Gland Neoplasms blood, Pheochromocytoma genetics, Pheochromocytoma metabolism, Pheochromocytoma pathology, Pheochromocytoma blood
- Abstract
Adrenal tumors, such as adrenocortical carcinoma (ACC), adrenocortical adenoma (ACA), and pheochromocytoma (PCC) are complex diseases with unclear causes and treatments. Mitochondria and mitochondrial-derived peptides (MDPs) are crucial for cancer cell survival. The primary aim of this study was to analyze samples from different adrenal diseases, adrenocortical carcinoma, adrenocortical adenoma, and pheochromocytoma, and compare them with normal adrenal tissue to determine whether the expression levels of the mitochondrial open reading frame of the 12S rRNA type-c (MOTS-c) gene and protein vary between different types of adrenal tumors compared to healthy controls using qPCR, ELISA, and IHC methods. Results showed decreased MOTS-c mRNA expression in all adrenal tumors compared to controls, while serum MOTS-c protein levels increased in ACA and PCC but not in ACC. The local distribution of MOTS-c protein in adrenal tissue was reduced in all tumors. Notably, MOTS-c protein expression declined with ACC progression (stages III and IV) but was unrelated to patient age or sex. Tumor size and testosterone levels positively correlated with MOTS-c mRNA but negatively with serum MOTS-c protein. Additionally, serum MOTS-c protein correlated positively with glucose, total cholesterol, HDL, LDL, and SHGB levels. These findings suggest disrupted expression of MOTS-c in the spectrum of adrenal diseases, which might be caused by mechanisms involving increased mitochondrial dysfunction and structural changes in the tissue associated with disease progression. This study provides a detailed examination of MOTS-c mRNA and protein in adrenal tumors, indicating the potential role of MDPs in tumor biology and progression., Competing Interests: The authors declare no conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF